DK2051693T3 - Letsynkelige farmaceutiske sammensætninger, der ikke forårsager en ubehagelig følelse i munden, og som omfatter partikler med et virksomt stof - Google Patents

Letsynkelige farmaceutiske sammensætninger, der ikke forårsager en ubehagelig følelse i munden, og som omfatter partikler med et virksomt stof

Info

Publication number
DK2051693T3
DK2051693T3 DK07801698.7T DK07801698T DK2051693T3 DK 2051693 T3 DK2051693 T3 DK 2051693T3 DK 07801698 T DK07801698 T DK 07801698T DK 2051693 T3 DK2051693 T3 DK 2051693T3
Authority
DK
Denmark
Prior art keywords
mouth
pharmaceutical composition
lightweight
cause
pharmaceutical compositions
Prior art date
Application number
DK07801698.7T
Other languages
English (en)
Inventor
Peter Kraahs
Peter Gruber
Original Assignee
Losan Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06017263A external-priority patent/EP1891936A1/de
Priority claimed from US11/516,573 external-priority patent/US8889184B2/en
Application filed by Losan Pharma Gmbh filed Critical Losan Pharma Gmbh
Application granted granted Critical
Publication of DK2051693T3 publication Critical patent/DK2051693T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK07801698.7T 2006-08-18 2007-08-16 Letsynkelige farmaceutiske sammensætninger, der ikke forårsager en ubehagelig følelse i munden, og som omfatter partikler med et virksomt stof DK2051693T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06017263A EP1891936A1 (de) 2006-08-18 2006-08-18 Gut schluckbare pharmazeutische Zusammensetzung aus einem oder mehreren wirkstoffhaltigen Teilchen ohne unangenehmes Mundgefühl
US11/516,573 US8889184B2 (en) 2006-09-07 2006-09-07 Particulate form of a pharmaceutical composition which is easy to swallow
PCT/EP2007/007243 WO2008019854A1 (en) 2006-08-18 2007-08-16 Pharmaceutical compositions easy to swallow, not causing any unpleasant oral sensation and comprising particles with an active principle

Publications (1)

Publication Number Publication Date
DK2051693T3 true DK2051693T3 (da) 2010-12-13

Family

ID=38596162

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07801698.7T DK2051693T3 (da) 2006-08-18 2007-08-16 Letsynkelige farmaceutiske sammensætninger, der ikke forårsager en ubehagelig følelse i munden, og som omfatter partikler med et virksomt stof

Country Status (8)

Country Link
EP (1) EP2051693B1 (da)
AT (1) ATE484275T1 (da)
BR (1) BRPI0715756B8 (da)
CA (1) CA2661575C (da)
DE (1) DE602007009846D1 (da)
DK (1) DK2051693T3 (da)
PL (1) PL2051693T3 (da)
WO (1) WO2008019854A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0908839A2 (pt) * 2008-03-05 2015-08-25 Lubrizol Advanced Mat Inc Sistema de dispensação de droga de liberação controlada, e, composição farmacêutica de liberação controlada
US20110111026A1 (en) * 2008-03-10 2011-05-12 Adel Penhasi Humidity-resistant drug formulations and methods of preparation thereof
WO2013090452A1 (en) 2011-12-12 2013-06-20 Orbis Biosciences, Inc. Sustained release particle formulations
US20230414597A1 (en) 2020-11-18 2023-12-28 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183775B1 (en) * 1996-05-13 2001-02-06 Novartis Consumer Health S.A. Buccal delivery system
US6709678B2 (en) * 1996-08-15 2004-03-23 Losan Pharma Gmbh Easy to swallow oral medicament composition
WO2005105036A1 (en) * 2004-04-28 2005-11-10 Natco Pharma Limited Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation

Also Published As

Publication number Publication date
EP2051693A1 (en) 2009-04-29
BRPI0715756A2 (pt) 2013-07-09
DE602007009846D1 (de) 2010-11-25
CA2661575C (en) 2014-06-17
EP2051693B1 (en) 2010-10-13
BRPI0715756B8 (pt) 2021-05-25
WO2008019854A1 (en) 2008-02-21
BRPI0715756B1 (pt) 2020-03-17
ATE484275T1 (de) 2010-10-15
CA2661575A1 (en) 2008-02-21
PL2051693T3 (pl) 2011-04-29

Similar Documents

Publication Publication Date Title
MX2009005727A (es) Nanoparticulas de entidad anfifilica.
WO2006058249A3 (en) Methods and compositions for deterring abuse of orally administered pharmaceutical products
DE69934505D1 (de) Im munde zerfallende tablette enthaltend ein benzimidazole
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
WO2008069941A3 (en) Modified release ibuprofen solid oral dosage form
MX2010006284A (es) Formulaciones farmaceuticas de fenilefrina y composiciones para la absorcion transmucosal.
MXPA05007643A (es) Metodo para producir una forma farmaceutica oral con desintegracion inmediata y liberacion de ingrediente activo.
RU2009146580A (ru) Состав, содержащий никотин, с покрытием для перорального применения с буферными свойствами, приданными аминокислотой
AR073851A1 (es) Forma de dosificacion intraoral de multiples porciones y uso de esta. sistema de suministro. formulacion
SI2529622T1 (en) Inhibitors of bruton's tyrosine kinase
DE60032749D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
EA201190127A1 (ru) Фармацевтические составы нитазоксанида с контролируемым высвобождением
RU2008149508A (ru) Покрытый фармацевтический продукт для доставки никотина в ротовую полость, включающий трометамол в качестве придающего буферные свойства агента
WO2007106550A3 (en) Methods and compositions for deterring abuse of orally administered pharmaceutical products
HRP20161444T1 (hr) Farmaceutski pripravci koji sadrže lokalni anestetik kao što je bupivakain za lokalnu primjenu u usta ili grlo
IL196425A0 (en) Pharmaceutical compositions containing ibuprofen and famotidine
NO20062051L (no) Farmasoytisk virkestoffinneholdende formulering med belegg
CY1116465T1 (el) Φαρμακοτεχνικη μορφη για προφυλαξη ασθενειων της στοματικης κοιλoτητας
US9662274B2 (en) Method of orally administering a treating agent over an extended period
PL2051693T3 (pl) Kompozycja farmaceutyczna, łatwa do połknięcia i nie powodująca nieprzyjemnych odczuć w ustach, zawierająca cząstki z substancją czynną
MX2010004556A (es) Formulacion farmaceutica de acido clavulanico.
MA32722B1 (fr) Formulation galénique renfermant de l'aliskirène et procédé associé de préparation par granulation par fusion-extrusion
WO2004037228A8 (en) Sustained release compositions containing alfuzosin
MXPA04004907A (es) Composiciones de acetaminofen.